Palo Alto Investors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Palo Alto Investors's GILD Position: Q1 2020 in Review
Palo Alto Investors sold out of Gilead Sciences (GILD) in Q1 2020, closing a stake of 39,300 shares — an estimated $2.55M sold.
Palo Alto Investors first reported a position in GILD in Q1 2014 and held it in 24 quarters. The position peaked at $35.1M in Q2 2015. 1,644 funds tracked by Wall St. Rank hold GILD as of Q1 2020.
- Palo Alto Investors reported no remaining Gilead Sciences position as of Q1 2020 after selling out during the quarter.
- Palo Alto Investors sold 39,300 Gilead Sciences shares in Q1 2020, an estimated $2.55M.
- Palo Alto Investors first reported a position in Gilead Sciences in Q1 2014 and held it in 24 quarters.
- Palo Alto Investors's Gilead Sciences position peaked at $35.1M in Q2 2015.
- 1,644 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2020.
Based on Palo Alto Investors's 13F filing for Q1 2020, filed 15 May 2020.